MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/wno.0000000000001684

Медицинская библиотека · Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2022

The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review.

Chwalisz Bart K, Levy Michael

СтатьяОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is an important etiology of neurologic morbidity and specifically, atypical, and relapsing optic neuritis. This review summarizes acute treatment and long-term prevention approaches in MOGAD.

EVIDENCE ACQUISITION: PubMed and Google Scholar databases were manually searched and reviewed.

RESULTS

We review the evidence base for acute treatment of MOGAD with corticosteroids and adjunct therapies, such as intravenous immunoglobulin (IVIg) and plasma exchange. We discuss the utility of prolonged corticosteroid tapering after the acute attack. We then summarize the commonly used disease-modifying treatments for relapsing MOGAD, including chronic low-dose corticosteroids, classic antirheumatic immune suppressants, biologic agents, and IVIg.

CONCLUSIONS

While acute MOGAD attacks are usually treated with high-dose IV corticosteroids, longer oral corticosteroid tapers may prevent rapid relapse. Multiple long-term treatment strategies are being employed in recurrent MOGAD, with IVIg is emerging as probably the most effective therapy.

Для цитирования: Chwalisz Bart K, Levy Michael. The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review.. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2022. DOI: 10.1097/wno.0000000000001684.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.